End-of-day quote
Taipei Exchange
06:00:00 2024-06-27 pm EDT
|
5-day change
|
1st Jan Change
|
50.9
TWD
|
+0.20%
|
|
+9.34%
|
+188.39%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
862.1
|
1,121
|
848.3
|
724.6
|
572
|
567.2
|
Enterprise Value (EV)
1 |
1,149
|
1,314
|
1,077
|
996.3
|
825.8
|
809.1
|
P/E ratio
|
9.45
x
|
9.33
x
|
121
x
|
-34.5
x
|
-14.4
x
|
-22.7
x
|
Yield
|
9.54%
|
5.02%
|
3.79%
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.17
x
|
1.45
x
|
1.64
x
|
1.86
x
|
1.5
x
|
2.02
x
|
EV / Revenue
|
1.56
x
|
1.7
x
|
2.08
x
|
2.56
x
|
2.17
x
|
2.88
x
|
EV / EBITDA
|
9.67
x
|
7.84
x
|
13.5
x
|
500
x
|
-27.6
x
|
-153
x
|
EV / FCF
|
18.4
x
|
8.9
x
|
17.4
x
|
-2,310
x
|
27.2
x
|
30.8
x
|
FCF Yield
|
5.43%
|
11.2%
|
5.76%
|
-0.04%
|
3.68%
|
3.24%
|
Price to Book
|
1.42
x
|
1.74
x
|
1.43
x
|
1.34
x
|
1.14
x
|
1.19
x
|
Nbr of stocks (in thousands)
|
32,133
|
32,133
|
32,133
|
32,133
|
32,133
|
32,133
|
Reference price
2 |
26.83
|
34.89
|
26.40
|
22.55
|
17.80
|
17.65
|
Announcement Date
|
4/22/19
|
4/28/20
|
4/28/21
|
4/27/22
|
4/21/23
|
4/25/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
737.1
|
774.3
|
516.9
|
389.8
|
381
|
280.7
|
EBITDA
1 |
118.9
|
167.6
|
79.5
|
1.992
|
-29.95
|
-5.285
|
EBIT
1 |
98.6
|
147.8
|
58.32
|
-19.68
|
-51.5
|
-25.66
|
Operating Margin
|
13.38%
|
19.09%
|
11.28%
|
-5.05%
|
-13.52%
|
-9.14%
|
Earnings before Tax (EBT)
1 |
109.5
|
145.3
|
8.553
|
-24.79
|
-47.26
|
-29.76
|
Net income
1 |
91.5
|
120.6
|
6.994
|
-21.01
|
-39.77
|
-24.94
|
Net margin
|
12.41%
|
15.57%
|
1.35%
|
-5.39%
|
-10.44%
|
-8.89%
|
EPS
2 |
2.840
|
3.740
|
0.2177
|
-0.6538
|
-1.238
|
-0.7761
|
Free Cash Flow
1 |
62.36
|
147.7
|
62.03
|
-0.4312
|
30.38
|
26.25
|
FCF margin
|
8.46%
|
19.08%
|
12%
|
-0.11%
|
7.97%
|
9.35%
|
FCF Conversion (EBITDA)
|
52.45%
|
88.13%
|
78.03%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
68.15%
|
122.53%
|
886.93%
|
-
|
-
|
-
|
Dividend per Share
2 |
2.560
|
1.750
|
1.000
|
-
|
-
|
-
|
Announcement Date
|
4/22/19
|
4/28/20
|
4/28/21
|
4/27/22
|
4/21/23
|
4/25/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
287
|
193
|
229
|
272
|
254
|
242
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.416
x
|
1.153
x
|
2.874
x
|
136.4
x
|
-8.475
x
|
-45.77
x
|
Free Cash Flow
1 |
62.4
|
148
|
62
|
-0.43
|
30.4
|
26.3
|
ROE (net income / shareholders' equity)
|
15.7%
|
19.3%
|
1.13%
|
-3.7%
|
-7.62%
|
-5.09%
|
ROA (Net income/ Total Assets)
|
5.57%
|
8.51%
|
3.46%
|
-1.24%
|
-3.45%
|
-1.74%
|
Assets
1 |
1,642
|
1,417
|
202.3
|
1,701
|
1,152
|
1,434
|
Book Value Per Share
2 |
18.90
|
20.10
|
18.50
|
16.90
|
15.60
|
14.90
|
Cash Flow per Share
2 |
3.780
|
3.540
|
3.620
|
2.140
|
3.820
|
4.890
|
Capex
1 |
81.5
|
71.7
|
23.6
|
10.3
|
2.99
|
2.4
|
Capex / Sales
|
11.06%
|
9.26%
|
4.56%
|
2.65%
|
0.78%
|
0.86%
|
Announcement Date
|
4/22/19
|
4/28/20
|
4/28/21
|
4/27/22
|
4/21/23
|
4/25/24
|
|
1st Jan change
|
Capi.
|
---|
| +188.39% | 50.35M | | +19.99% | 67.97B | | -6.03% | 45.92B | | +22.27% | 43.74B | | +33.20% | 28.16B | | +8.15% | 19.17B | | +14.71% | 17.12B | | -13.18% | 14.73B | | -27.99% | 14.52B | | -32.33% | 11.64B |
Other Specialty Chemicals
|